Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

AMMONIA N 13

AMMONIA N-13

Standard Dose
22.5mCi-225mCi/6ML (3.75-37.5mCi/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview AMMONIA N 13 is listed in Drugs@FDA under application 210524 (ANDA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient AMMONIA N-13 Form and strength INJECTABLE;INTRAVENOUS - 22.5mCi-225mCi/6ML (3.75-37.5mCi/ML) Sponsor IONETIX Submission history Latest submission status date: 2020-01-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMMONIA N 13 is listed in Drugs@FDA under application 210524 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient AMMONIA N-13 Form and strength INJECTABLE;INTRAVENOUS - 22.5mCi-225mCi/6ML (3.75-37.5mCi/ML) Sponsor IONETIX Submission history Latest submission status date: 2020-01-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.